Filing Details

Accession Number:
0001562180-20-001250
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-14 17:09:12
Reporting Period:
2020-02-12
Accepted Time:
2020-02-14 17:09:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434418 Constellation Pharmaceuticals Inc CNST Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1437152 Karen Valentine C/O Constellation Pharmaceuticals, Inc.
215 First Street, Suite 200
Cambridge MA 02142
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-12 1,500 $11.50 1,500 No 4 M Direct
Common Stock Disposition 2020-02-12 1,500 $35.02 0 No 4 S Direct
Common Stock Acquisiton 2020-02-13 1,906 $8.76 1,906 No 4 M Direct
Common Stock Acquisiton 2020-02-13 2,567 $11.50 4,473 No 4 M Direct
Common Stock Disposition 2020-02-13 4,473 $35.07 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-02-12 1,500 $0.00 1,500 $11.50
Common Stock Stock Option (Right to Buy) Disposition 2020-02-13 2,567 $0.00 2,567 $11.50
Common Stock Stock Option (Right to Buy) Disposition 2020-02-13 1,906 $0.00 1,906 $8.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
123,039 2028-07-18 No 4 M Direct
120,472 2028-07-18 No 4 M Direct
26,144 2029-03-06 No 4 M Direct
Footnotes
  1. These trades were made pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This option was granted on July 19, 2018 and is scheduled to vest as to 25% of the shares underlying the option on July 16, 2019, with the remainder vesting in equal quarterly installments through July 16, 2022, subject to continued service.
  5. This option was granted on March 7, 2019, and the shares underlying the option vest in equal quarterly installments through March 7, 2023, subject to continued service.